Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.
The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.
Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that.
In this Science Surgery post we explore the work being done to use existing treatments in other types of cancer.
CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research.
By combining radiotherapy with different kinds of drugs, scientists hope that both can be made more effective.